Loading stock data…
IRTC
$113.53+6.31 (+5.88%)
Market OpenUpdated 3:50 PM EDT
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
iRhythm Holdings, Inc. in the Healthcare sector is trading at $113.53. Wall Street consensus targets $178.93 (14 analysts), implying a +57.6% move over the next 12 months. The stock is currently near its 52-week low of $101.75, remaining 25.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +57.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$113.53
Potential Downside
0%
Whystock Fair Value$113.53
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus14 analysts
Mean target$178.93+57.6%
Range$147.00 – $255.00
Fundamentals
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-17.23%
Volume
Today's trading volume
452,108
Recent News
A Look At iRhythm Holdings (IRTC) Valuation After Governance Changes And Litigation Settlement
iRhythm Holdings (IRTC) is back in focus after shareholders approved an amended Certificate of Incorporation and the company entered a settlement agreement related to earlier class action securities litigation, which is sharpening attention on governance and risk. See our latest analysis for iRhythm Holdings. Recent governance changes and the litigation settlement are playing out against a weaker share price backdrop, with the stock at US$108.11 and the year to date share price return down...
iRhythm Holdings (IRTC) was Trimmed Following Strong Performance
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Small Cap Fund”. A copy of the letter is available to download here. US equities were mixed in Q1 2026, with major indices hitting all-time highs in January before retreating amid geopolitical tensions, changing monetary policy, and economic uncertainty. Energy […]
2 Reasons to Like IRTC and 1 to Stay Skeptical
iRhythm’s stock price has taken a beating over the past six months, shedding 37.6% of its value and falling to $114.01 per share. This may have investors wondering how to approach the situation.
3 of Wall Street’s Favorite Stocks on Our Watchlist
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
2 Small-Cap Stocks with Solid Fundamentals and 1 Facing Headwinds
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.